Oestrogen metabolites in relation to isoprostanes as a measure of oxidative stress

Clinical Endocrinology

Volumn 68, Issue 5, 2008, Pages 806-813

  Sowers, MaryFran ^a,b   McConnell, Daniel ^a   Jannausch, Mary L ^a   Randolph Jr , John F ^b   Brook, Robert ^c   Gold, Ellen B ^d   Crawford, Sybil ^e   Lasley, Bill ^f  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA HYDROXYESTRONE; 2 HYDROXYESTRONE; ESTRADIOL; F2A ISOPROSTANE; ISOPROSTANE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CORRELATION ANALYSIS; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRADIOL BLOOD LEVEL; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; METABOLITE; OXIDATIVE STRESS; PRIORITY JOURNAL; SMOKING; UNITED STATES;

EID: 42149117979     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.03108.x     Document Type: Article

References (53)

1. 2-isoprostanes as indices of lipid peroxidation in inflammatory diseases. Chemistry and Physics of Lipids, 128, 165 171.
2. Halliwell, B. (1998) Can oxidative DNA damage be used as a biomarker of cancer risk in humans? Problems, resolutions, and preliminary results from nutritional supplementation studies. Free Radical Research, 29, 469 486.
3. Arteaga, E., Rojas, A., Villaseca, P., Bianchi, M., Arteaga, A. Durán, D. (1998) In vitro effect of estradiol, progesterone, testosterone, and of combined estradiol/progestins on low density lipoprotein (LDL) oxidation in postmenopausal women. Menopause, 5, 16 23.
4. Moosmann, B. Behl, C. (1999) The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proceedings of the National Academy of Sciences of the United States of America, 96, 8867 8872.
5. Witztum, J.L. Steinberg, D. (1991) Role of oxidized low density lipoprotein in atherogenesis. Journal of Clinical Investigation, 88, 1785 1792.
6. Cracowski, J.L. Ormezzano, O. (2004) Isoprostanes, emerging biomarkers and potential mediators in cardiovascular diseases. European Heart Journal, 25, 1675 1678.
7. Sack, M.N., Rader, D.J. Cannon, R.O. III. (1994) Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet, 343, 269 270.
8. Wakatsuki, A., Ikenoue, N. Sagara, Y. (1998) Effects of estrogen on susceptibility to oxidation of low-density and high-density lipoprotein in postmenopausal women. Maturitas, 28, 229 234.
9. Hermenegildo, C., García-Martínez, M.C., Tarín, J.J. Cano, A. (2002) Inhibition of low-density lipoprotein oxidation by the pure antiestrogens ICI 182780 and EM-652 (SCH 57068). Menopause, 9, 430 435.
10. Santanam, N., Shern-Brewer, R., McClatchey, R., Castellano, P.Z., Murphy, A.A., Voelkel, S. Parthasarathy, S. (1998) Estradiol as an antioxidant: incompatible with its physiological concentrations and function. Journal of Lipid Research, 39, 2111 2118.
11. Ide, T., Tsutsui, H., Ohashi, N., Hayashidani, S., Suematsu, N., Tsuchihashi, M., Tamai, H. Takeshita, A. (2002) Greater oxidative stress in healthy young men compared with premenopausal women. Arteriosclerosis, Thrombosis, and Vascular Biology, 22, 438 442.
12. Block, G., Dietrich, M., Norkus, E.P., Morrow, J.D., Hudes, M., Caan, B. Packer, L. (2002) Factors associated with oxidative stress in human populations. American Journal of Epidemiology, 156, 274 285.
13. Keaney, J.F. Jr., Larson, M.G., Vasan, R.S., Wilson, P.W., Lipinska, I., Corey, D., Massaro, J.M., Sutherland, P., Vita, J.A. Benjamin, E.J. (2003) Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 434 439.
14. 2-isoprostane excretion rates in migraine. Clinical Science, 102, 39 43.
15. Morrow, J.D. (2005) Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 279 286.
16. 2- isoprostanes as an index of oxidative stress in vivo. Free Radical Biology and Medicine, 28, 505 513.
17. Hartman, T.J., Baer, D.J., Graham, L.B., Stone, W.L., Gunter, E.W., Parker, C.E., Albert, P.S., Dorgan, J.F., Clevidence, B.A., Campbell, W.S., Tomer, K.B., Judd, J.T. Taylor, P.R. (2005) Moderate alcohol consumption and levels of antioxidant vitamins and isoprostanes in postmenopausal women. European Journal of Clinical Nutrition, 59, 161 168.
18. Sowers, M.F., Crawford, S., Sternfeld, B., Morgenstein, D., Gold, E., Greendale, G., Evans, D., Neer, R., Matthews, K., Sherman, S., Lo, A., Weiss, G. Kelsey, J. (2000) Design, survey sampling and recruitment methods of SWAN: a multi-center, multi-ethnic, community-based cohort study of women and the menopausal transition. In : R.A. Lobo, J. Kelsey, R. Marcus eds. Menopause: Biology and Pathobiology. Academic Press, San Diego, 175 188.
19. Klug, T.L., Bradlow, H.L. Sepkovic, D.W. (1994) Monoclonal antibody-based enzyme immunoassay for simultaneous quantitation of 2- and 16α- hydroxyestrone in urine. Steroids, 59, 648 655.
20. Myers, G.L., Cooper, G.R., Winn, C.L. Smith, S.J. (1989) The Centers for Disease Control-National Heart, Lung, and Blood Institute Lipid Standardization Program: an approach to accurate and precise lipid measurements. Clinical Laboratory Medicine, 9, 105 135.
21. Ferris, B.G. (1978) Epidemiology Standardization Project (American Thoracic Society). American Review of Respiratory Disease, 118, 1 20.
22. Coghlin, J., Hammond, S.K. Gann, P.H. (1989) Development of epidemiologic tools for measuring environmental tobacco smoke exposure. American Journal of Epidemiology, 130, 696 704.
23. Sternfeld, B., Ainsworth, B.E. Quesenbury, C.P. Jr. (1999) Physical activity patterns in a diverse population of women. Preventive Medicine, 28, 313 323.
24. Block, G., Hartman, A.M., Dresser, C.M., Carroll, M.D., Gannon, J. Gardner, L. (1986) A data-based approach to diet questionnaire design and testing. American Journal of Epidemiology, 124, 453 469.
25. Reinli, K. Block, G. (1996) Phytoestrogen content of foods - a compendium of literature values. Nutrition and Cancer, 26, 123 148.
26. Sowers, M.R., Crawford, S., McConnell, D.S., Randolph, J.F. Jr., Gold, E.B., Wilkin, M.K. Lasley, B. (2006) Selected diet and lifestyle factors are associated with estrogen metabolites in a multi-racial/ethnic population of women. Journal of Nutrition, 136, 1588 1595.
27. Nathan, L. Chaudhuri, G. (1998) Antioxidant and prooxidant actions of estrogens: potential physiological and clinical implications. Seminars in Reproductive Endocrinology, 16, 309 314.
28. Tang, M., Abplanalp, W., Ayres, S. Subbiah, M.T. (1996) Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation. Metabolism: Clinical and Experimental, 45, 411 414.
29. Seeger, H., Mueck, A.O. Lippert, T.H. (1997) Effect of estradiol metabolites on the susceptibility of low density lipoprotein to oxidation. Life Sciences, 61, 865 868.
30. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proceedings of the National Academy of Sciences of the United States of America, 87, 9383 9387.
31. de Zwart, L.L., Meerman, J.H., Commandeur, J.N. Vermeulen, N.P. (1999) Biomarkers of free radical damage applications in experimental animals and humans. Free Radical Biology and Medicine, 26, 202 226.
32. Cracowski, J.L., Cracowski, C., Bessard, G., Pepin, J.L., Bessard, J., Schwebel, C., Stanke-Labesque, F. Pison, C. (2001) Increased lipid peroxidation in patients with pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine, 164, 1038 1042.
33. McKinney, K.A., Duell, P.B., Wheaton, D.L., Hess, D.L., Patton, P.E., Spies, H.G. Burry, K.A. (1997) Differential effects of subcutaneous estrogen and progesterone on low-density lipoprotein size and susceptibility to oxidation in postmenopausal rhesus monkeys. Fertility and Sterility, 68, 525 530.
34. Richelle, M., Turini, M.E., Guidoux, R., Tavazzi, I., Métairon, S. Fay, L.B. (1999) Urinary isoprostane excretion is not confounded by the lipid content of the diet. FEBS Letters, 459, 259 262.
35. 2-isoprostanes) in smokers. New England Journal of Medicine, 332, 1198 1203.
36. Reilly, M., Delanty, N., Lawson, J.A. FitzGerald, G.A. (1996) Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation, 94, 19 25.
37. 2α is increased in hypercholesterolemia. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 3230 3235.
38. 2 isoprostanes in hypercholesterolemia. Circulation, 98, 2822 2828.
39. 2α and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation, 99, 224 229.
40. Pratico, D., Iuliano, L., Basili, S., Ferro, D., Camastra, C., Cordova, C., FitzGerald, G.A. Violi, F. (1998) Enhanced lipid peroxidation in hepatic cirrhosis. Journal of Medical Investigation, 46, 51 57.
41. Kumar, K., Thangaraju, M. Sachdanandam, P. (1991) Changes observed in antioxidant system in the blood of postmenopausal women with breast cancer. Biochemistry International, 25, 371 380.
42. 2α in the arterial wall layers of various species: a comparison between intact and atherosclerotic areas. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 64, 167 171.
43. 2-isoprostane levels. Free Radical Biology and Medicine, 28, 806 814.
44. Hinchcliff, K.W., Reinhart, G.A., DiSilvestro, R., Reynolds, A., Blostein-Fujii, A. Swenson, R.A. (2000) Oxidant stress in sled dogs subjected to repetitive endurance exercise. American Journal of Veterinary Research, 61, 512 517.
45. Kirschvink, N., Smith, N., Fievez, L., Bougnet, V., Art, T., Degand, G., Marlin, D., Roberts, C., Genicot, B., Lindsey, P. Lekeux, P. (2002) Effect of chronic airway inflammation and exercise on pulmonary and systematic antioxidant status of healthy and heaves-affected horses. Equine Veterinary Journal, 34, 563 571.
46. Mastaloudis, A., Leonard, S.W. Traber, M.G. (2001) Oxidative stress in athletes during extreme endurance exercise. Free Radical Biology and Medicine, 31, 911 922.
47. 2-isoprostanes as markers of in vivo lipid peroxidation - a comparison of enzyme immunoassay with gas chromatography/mass spectrometry. Analytical Biochemistry, 272, 209 215.
48. 2-isoprostanes as measures of oxidative stress in Type 2 diabetes. Clinical Chemistry, 47, 1974 1979.
49. Walsh, S.W., Vaughan, J.E., Wang, Y. Roberts, L.J. II. (2000) Placenta isoprostane is significantly increased in preeclampsia. FASEB Journal, 14, 1289 1296.
50. Meagher, E.A., Barry, O.P., Lawson, J.A., Rokach, J. FitzGerald, G.A. (2001) Effects of vitamin E on lipid peroxidation in healthy persons. Journal of the American Medical Association, 285, 1178 1182.
51. 2α-I: an index of lipid peroxidation in humans. Proceedings of the National Academy of Sciences of the United States of America, 95, 3449 3454.
52. 2α excretion in man. Journal of Pharmacology and Experimental Therapeutics, 275, 94 100.
53. 2α in human plasma and urine by liquid chromatography-electrospray ionization mass spectrometry. Journal of Chromatography B: Biomedical Sciences and Applications, 746, 17 24.